"Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety" by Reshma Mahtani

Article

Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety

BMC Cancer (2021)

Reshma Mahtani, Baptist Health South Florida
Jeffrey Crawford, University of Texas MD Anderson Cancer Center
Sinéad M. Flannery
Tatiana Lawrence
Jennifer Schenfeld
Prasad L. Gawade

Link

Disciplines

Medicine and Health Sciences

Publication Date

2021

Citation Information

Reshma Mahtani, Jeffrey Crawford, Sinéad M. Flannery, Tatiana Lawrence, et al.. "Prophylactic Pegfilgrastim to Prevent Febrile Neutropenia Among Patients Receiving Biweekly (Q2W) Chemotherapy Regimens: a Systematic Review of Efficacy, Effectiveness and Safety" BMC Cancer Vol. 21 Iss. 1 (2021)
Available at: http://works.bepress.com/reshma-mahtani/96/